Well, I and you, both want to know what Merck's plan is for this setting, and I really do not know what the hold-up is, other than them thinking they are going to get more money and more use out of a combination study...I guess we'll see.
BTW, while you're here....could you PLEASE clear up biotech_"researchers" obvious confusion and misquoting AP regarding the OS data (he continues to insist the abstract says something it didnt).